ClinicalTrials.gov
ClinicalTrials.gov Menu

Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00657514
Recruitment Status : Withdrawn (Insufficient enrollment)
First Posted : April 14, 2008
Last Update Posted : August 15, 2014
Sponsor:
Information provided by (Responsible Party):
Mark Nehler, MD, Colorado Prevention Center